RAGE ADC effective in fight against ovarian and prostate cancer
Researchers at Swansea University have shown a that novel antibody drug conjugate (ADC) is highly effective in two cancers with clinical unmet need. Prof. Steve Conlan and WCRC- funded researcher… Read More »RAGE ADC effective in fight against ovarian and prostate cancer